Premium
Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Author(s) -
Graves Sara I.,
Baker Darren J.
Publication year - 2020
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/bcpt.13403
Subject(s) - senescence , blood–brain barrier , ageing , neurovascular bundle , microbiology and biotechnology , endothelial stem cell , biology , aging brain , endothelial dysfunction , cellular senescence , phenotype , endothelium , neuroscience , disease , medicine , pathology , central nervous system , endocrinology , anatomy , in vitro , biochemistry , genetics , gene
Cerebrovascular endothelial cells (CECs) are integral components of both the blood‐brain barrier (BBB) and the neurovascular unit (NVU). As the primary cell type of the BBB, CECs are responsible for the tight regulation of molecular transport between the brain parenchyma and the periphery. Additionally, CECs are essential in neurovascular coupling where they help regulate cerebral blood flow in response to regional increases in cellular demand in the NVU. CEC dysfunction occurs during both normative ageing and in cerebrovascular disease, which leads to increased BBB permeability and neurovascular uncoupling. This MiniReview compiles what is known about the molecular changes underlying CEC dysfunction, many of which are reminiscent of cells that have become senescent. In general, cellular senescence is defined as an irreversible growth arrest characterized by the acquisition of a pro‐inflammatory secretory phenotype in response to DNA damage or other cellular stresses. We discuss evidence for endothelial cell senescence in ageing and cardiovascular disease, and how CEC senescence may contribute to age‐related cerebrovascular dysfunction.